Press Releases by Year
Nanology in the News
Presentations & Publications
Nov 12-15 : Society of Neuro-Oncology 31st Annual Meeting | Philadelphia
Jan 11-14 : JP Morgan 45th Annual Healthcare Conference
NanOlogy, LLC CEO David J. Arthur Discusses Their PURCISIONTM Technology Advancing Intratumoral Therapy to Treat Cancer
NanOlogy Appoints John M. Goldberg, MD as Chief Medical Officer to Further its Preclinical & Clinical Large Surface Area Microparticle Investigational Drug Portfolio
NanOlogy Appoints David J. Arthur as Chief Executive Officer to Drive Clinical Development of its Large Surface Area Microparticle (LSAM) Investigational Drug Portfolio
See All Press Releases
CEOCFO Magazine: NanOlogy – Advancing their PURCISION™ Technology using Intratumoral Therapy to Solve the Toxicity Problem when Treating Cancer
OncLive: LSAM-PTX Demonstrates Disease Control, Safety in Locally Advanced Pancreatic Cancer
OncLive: LSAM-DTX Effective and Safe in NMIBC Using Direct, Multifaceted Approach
See Nanology in the News Archive
Journal of Personalized Medicine: Intratumoral Therapeutic Injections for Lung Cancer: Current Evidence, Personalized Therapeutic Approaches, and Future Directions
Therapeutic Advances in Medical Oncology: Systemic and locoregional therapies for cutaneous metastases from breast cancer: state of art and new frontiers in treatment approach
European Urology: A Systemic Review of Novel Intravesical Approaches for the Treatment of Patients with Non-muscle-invasive Bladder Cancer
Journal of Thoracic Oncology: Phase 2a Intratumoral Large Surface Area Microparticle Paclitaxel in Stage 3/4 Lung Cancer
JDDG: Cutaneous metastases: From epidemiology to therapy
See All Presentations & Publications
